{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:34:32Z","timestamp":1794922472487,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016258","name":"Institute of Civil-Military Technology Cooperation","doi-asserted-by":"publisher","award":["22-CM-EC-18"],"award-info":[{"award-number":["22-CM-EC-18"]}],"id":[{"id":"10.13039\/501100016258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To overcome cross-species immunological barriers, researchers utilize gene editing to remove the expression of three major carbohydrate xenoantigens (\n                    <jats:italic>\u03b1-Gal<\/jats:italic>\n                    ,\n                    <jats:italic>Neu5Gc<\/jats:italic>\n                    ,\n                    <jats:italic>and Sd(a)<\/jats:italic>\n                    ) and insert genes, such as human protective genes (\n                    <jats:italic>hCD55 and hCD39<\/jats:italic>\n                    ). This study aimed to investigate the mechanisms underlying long-term hepatic injury following xenotransfusion of genetically modified pig red blood cells (pRBCs). We xenotransfused pRBCs genetically engineered with GGTA1\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    (\n                    <jats:italic>\u03b1-Gal<\/jats:italic>\n                    <jats:sup>\u2212)<\/jats:sup>\n                    ; CMAH\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    (\n                    <jats:italic>Neu5Gc<\/jats:italic>\n                    <jats:sup>\u2212<\/jats:sup>\n                    ); \u03b24GALNT2\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    (\n                    <jats:italic>Sd(a)<\/jats:italic>\n                    <jats:sup>\u2212<\/jats:sup>\n                    <jats:italic>)<\/jats:italic>\n                    ;\n                    <jats:italic>hCD55; hCD39<\/jats:italic>\n                    into a non-human primate (NHP) model of acute hemorrhage hemolysis and evaluated the long-term immune response to xenogeneic RBCs in the liver, a key organ for RBC metabolism. Immediately after xenotransfusion (D\u2009+\u20091), significant elevations of liver enzymes (AST, ALT) and iron-related factors were observed in the serum levels of the recipients, which were normalized by D\u2009+\u200921. However, long-term analysis revealed excessive accumulation of iron ions in the liver and decreased expression of antioxidant enzymes. The resulting endoplasmic reticulum stress (increased GRP78\/BiP expression), lipid peroxide accumulation, and iron-dependent cell death (ferroptosis) persisted in the liver of the recipient. These results suggest that, beyond gene editing, additional hurdles must be overcome to completely block oxidative stress damage caused by impaired RBC lysis. Notably, transcriptomic and immunohistochemical analyses in the NHP model identified the direct role of ferroptosis in xenotransfusion-induced liver injury. Therefore, we propose that a multilayered approach, including blocking the ROS-Iron axis and administering ferroptosis inhibitors, is needed to ensure long-term safety in the clinical development of xenotransfusion.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30021-5","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:45:28Z","timestamp":1765907128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hemolysis-induced hepatic ferroptosis following xenotransfusion of genetically modified pig red blood cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Ha-Young","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Ryong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo-Hwa","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohyun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Ho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"12","key":"30021_CR1","first-page":"CD002042","volume":"12","author":"JL Carson","year":"2021","unstructured":"Carson, J. L. et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst. Rev. 12 (12), CD002042 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"30021_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cll.2021.07.004","volume":"41","author":"YC Tanhehco","year":"2021","unstructured":"Tanhehco, Y. C. Red blood cell transfusion. Clin. Lab. Med. 41 (4), 611\u2013619 (2021).","journal-title":"Clin. Lab. Med."},{"issue":"4","key":"30021_CR3","doi-asserted-by":"publisher","first-page":"150758","DOI":"10.1016\/j.tmrv.2023.150758","volume":"37","author":"RM Fasano","year":"2023","unstructured":"Fasano, R. M. et al. Optimizing RBC transfusion outcomes in patients with acute illness and in the chronic transfusion setting. Transfus. Med. Rev. 37 (4), 150758 (2023).","journal-title":"Transfus. Med. Rev."},{"issue":"4","key":"30021_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tmrv.2017.07.003","volume":"31","author":"ND Nielsen","year":"2017","unstructured":"Nielsen, N. D., Martin-Loeches, I. & Wentowski, C. The effects of red blood cell transfusion on tissue oxygenation and the microcirculation in the intensive care unit: A systematic review. Transfus. Med. Rev. 31 (4), 205\u2013222 (2017).","journal-title":"Transfus. Med. Rev."},{"issue":"4","key":"30021_CR5","first-page":"292","volume":"20","author":"E Grandone","year":"2022","unstructured":"Grandone, E. et al. Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic. Blood Transfus. 20 (4), 292\u2013298 (2022).","journal-title":"Blood Transfus."},{"issue":"4","key":"30021_CR6","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1016\/S2542-5196(25)00051-8","volume":"9","author":"E Viennet","year":"2025","unstructured":"Viennet, E. et al. Blood under pressure: how climate change threatens blood safety and supply chains. Lancet Planet. Health. 9 (4), e304\u2013e313 (2025).","journal-title":"Lancet Planet. Health"},{"issue":"4","key":"30021_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000365401","volume":"41","author":"T Zeiler","year":"2014","unstructured":"Zeiler, T., Lander-Kox, J. & Alt, T. Blood donation by elderly repeat blood donors. Transfus. Med. Hemother. 41 (4), 242\u2013250 (2014).","journal-title":"Transfus. Med. Hemother"},{"issue":"2","key":"30021_CR8","first-page":"145","volume":"15","author":"C Sut","year":"2017","unstructured":"Sut, C. et al. Duration of red blood cell storage and inflammatory marker generation. Blood Transfus. 15 (2), 145\u2013152 (2017).","journal-title":"Blood Transfus."},{"issue":"1","key":"30021_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1537-2995.2012.03656.x","volume":"53","author":"A Pereira","year":"2013","unstructured":"Pereira, A. Will clinical studies elucidate the connection between the length of storage of transfused red blood cells and clinical outcomes? An analysis based on the simulation of randomized controlled trials. Transfusion 53 (1), 34\u201340 (2013).","journal-title":"Transfusion"},{"issue":"11","key":"30021_CR10","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1111\/trf.16667","volume":"61","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto, T. et al. Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease. Transfusion 61 (11), 3104\u20133118 (2021).","journal-title":"Transfusion"},{"key":"30021_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.blre.2019.01.003","volume":"35","author":"B Smood","year":"2019","unstructured":"Smood, B. et al. Genetically-engineered pigs as sources for clinical red blood cell transfusion: what Pathobiological barriers need to be overcome? Blood Rev. 35, 7\u201317 (2019).","journal-title":"Blood Rev."},{"issue":"2","key":"30021_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0037-1963(00)90039-8","volume":"37","author":"A Zhu","year":"2000","unstructured":"Zhu, A. Introduction to Porcine red blood cells: implications for xenotransfusion. Semin Hematol. 37 (2), 143\u2013149 (2000).","journal-title":"Semin Hematol."},{"issue":"1","key":"30021_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12152","volume":"258","author":"A Griesemer","year":"2014","unstructured":"Griesemer, A., Yamada, K. & Sykes, M. Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol. Rev. 258 (1), 241\u2013258 (2014).","journal-title":"Immunol. Rev."},{"issue":"3","key":"30021_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ajt.2022.12.023","volume":"23","author":"DKC Cooper","year":"2023","unstructured":"Cooper, D. K. C. & Pierson, R. N. Milestones on the path to clinical pig organ xenotransplantation. Am. J. Transpl. 23 (3), 326\u2013335 (2023).","journal-title":"Am. J. Transpl."},{"issue":"2","key":"30021_CR15","first-page":"150","volume":"381","author":"SR Panch","year":"2019","unstructured":"Panch, S. R., Montemayor-Garcia, C. & Klein, H. G. Hemolytic Transfus. React. N Engl. J. Med.  381 (2): 150\u2013162. (2019).","journal-title":"Hemolytic Transfus. React. N Engl. J. Med."},{"issue":"4","key":"30021_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/xen.12106","volume":"21","author":"ZY Wang","year":"2014","unstructured":"Wang, Z. Y. et al. Erythrocytes from GGTA1\/CMAH knockout pigs: implications for xenotransfusion and testing in non-human primates. Xenotransplantation 21 (4), 376\u2013384 (2014).","journal-title":"Xenotransplantation"},{"key":"30021_CR17","doi-asserted-by":"crossref","unstructured":"Lu, T. Y. et al. Advances in innate immunity to overcome immune rejection during xenotransplantation. Cells 11 (23). (2022).","DOI":"10.3390\/cells11233865"},{"issue":"3","key":"30021_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/xen.12161","volume":"22","author":"JL Estrada","year":"2015","unstructured":"Estrada, J. L. et al. Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1\/CMAH\/beta4GalNT2 genes. Xenotransplantation 22 (3), 194\u2013202 (2015).","journal-title":"Xenotransplantation"},{"issue":"5","key":"30021_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11248-021-00271-w","volume":"30","author":"J Shim","year":"2021","unstructured":"Shim, J. et al. Human immune reactivity of GGTA1\/CMAH\/A3GALT2 triple knockout Yucatan miniature pigs. Transgenic Res. 30 (5), 619\u2013634 (2021).","journal-title":"Transgenic Res."},{"issue":"1","key":"30021_CR20","doi-asserted-by":"publisher","first-page":"29870","DOI":"10.1038\/s41598-024-81730-2","volume":"14","author":"B Fang","year":"2024","unstructured":"Fang, B. et al. Generation and characterization of genetically modified pigs with GGTA1\/beta4GalNT2\/CMAH knockout and human CD55\/CD47 expression for xenotransfusion studies. Sci. Rep. 14 (1), 29870 (2024).","journal-title":"Sci. Rep."},{"issue":"3","key":"30021_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jtcvs.2022.04.032","volume":"166","author":"DKC Cooper","year":"2023","unstructured":"Cooper, D. K. C. et al. Shooting for the moon: genome editing for pig heart xenotransplantation. J. Thorac. Cardiovasc. Surg. 166 (3), 973\u2013980 (2023).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"30021_CR22","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.3389\/ti.2024.13681","volume":"37","author":"A Ali","year":"2024","unstructured":"Ali, A. et al. What genetic modifications of source pigs are essential and sufficient for Cell, Tissue, and organ xenotransplantation? Transpl. Int. 37, 13681 (2024).","journal-title":"Transpl. Int."},{"key":"30021_CR23","doi-asserted-by":"crossref","unstructured":"Sandrin, M. S. & McKenzie, I. F. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol. Rev. 141,  169\u2009\u2013\u200990. (1994).","DOI":"10.1111\/j.1600-065X.1994.tb00877.x"},{"issue":"8","key":"30021_CR24","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1111\/ajt.12744","volume":"14","author":"C Burlak","year":"2014","unstructured":"Burlak, C. et al. Reduced binding of human antibodies to cells from GGTA1\/CMAH KO pigs. Am. J. Transpl. 14 (8), 1895\u20131900 (2014).","journal-title":"Am. J. Transpl."},{"key":"30021_CR25","doi-asserted-by":"crossref","unstructured":"Kang, H. J. et al. Complement Activation and Hemolysis in Non-Human Primates Following Transfusion of Genetically Modified Pig Red Blood Cells (Ann Lab Med, 2025).","DOI":"10.3343\/alm.2024.0443"},{"key":"30021_CR26","doi-asserted-by":"publisher","first-page":"1436897","DOI":"10.3389\/fphys.2024.1436897","volume":"15","author":"TL Duarte","year":"2024","unstructured":"Duarte, T. L. et al. Heme (dys)homeostasis and liver disease. Front. Physiol. 15, 1436897 (2024).","journal-title":"Front. Physiol."},{"issue":"5","key":"30021_CR27","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2004-04-1578","volume":"105","author":"FL Willekens","year":"2005","unstructured":"Willekens, F. L. et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105 (5), 2141\u20132145 (2005).","journal-title":"Blood"},{"issue":"6","key":"30021_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 136 (6), 726\u2013739 (2020).","journal-title":"Blood"},{"key":"30021_CR29","first-page":"655393","volume":"12","author":"P Thiagarajan","year":"2021","unstructured":"Thiagarajan, P., Parker, C. J. & Prchal, J. T. How Do Red Blood Cells Die? Front. Physiol., 12: 655393. (2021).","journal-title":"How Do Red Blood Cells Die? Front. Physiol."},{"issue":"7","key":"30021_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbagen.2008.09.010","volume":"1790","author":"CP Ozment","year":"2009","unstructured":"Ozment, C. P. & Turi, J. L. Iron overload following red blood cell transfusion and its impact on disease severity. Biochim. Biophys. Acta. 1790 (7), 694\u2013701 (2009).","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"30021_CR31","first-page":"305","volume":"56","author":"P Lipinski","year":"2010","unstructured":"Lipinski, P. et al. [Iron homeostasis, a defense mechanism in oxidative stress]. Postepy Biochem. 56 (3), 305\u2013316 (2010).","journal-title":"Postepy Biochem."},{"key":"30021_CR32","doi-asserted-by":"crossref","unstructured":"Kawabata, T. Iron-Induced oxidative stress in human diseases. Cells 11 (14). (2022).","DOI":"10.3390\/cells11142152"},{"key":"30021_CR33","doi-asserted-by":"crossref","unstructured":"Orrico, F. et al. Oxidative stress in healthy and pathological red blood cells. Biomolecules 13 (8). (2023).","DOI":"10.3390\/biom13081262"},{"key":"30021_CR34","doi-asserted-by":"publisher","first-page":"101113","DOI":"10.1016\/j.blre.2023.101113","volume":"61","author":"Y Chornenkyy","year":"2023","unstructured":"Chornenkyy, Y. et al. Future prospects for the clinical transfusion of pig red blood cells. Blood Rev. 61, 101113 (2023).","journal-title":"Blood Rev."},{"issue":"2","key":"30021_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5625\/lar.2016.32.2.79","volume":"32","author":"HK Park","year":"2016","unstructured":"Park, H. K. et al. Reference values of clinical pathology parameters in cynomolgus monkeys (Macaca fascicularis) used in preclinical studies. Lab. Anim. Res. 32 (2), 79\u201386 (2016).","journal-title":"Lab. Anim. Res."},{"key":"30021_CR36","doi-asserted-by":"crossref","unstructured":"Bakker, J. et al. Reference intervals and percentiles for hematologic and serum biochemical values in captive bred rhesus (Macaca mulatta) and cynomolgus macaques (Macaca fascicularis). Anim. (Basel) 13 (3). (2023).","DOI":"10.3390\/ani13030445"},{"issue":"1","key":"30021_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41420-022-01212-0","volume":"8","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. GPX4-independent ferroptosis-a new strategy in disease\u2019s therapy. Cell. Death Discov. 8 (1), 434 (2022).","journal-title":"Cell. Death Discov"},{"issue":"2","key":"30021_CR38","first-page":"e1052","volume":"6","author":"JT Ross","year":"2024","unstructured":"Ross, J. T. et al. Cell-Free hemoglobin in the pathophysiology of trauma: A scoping review. Crit. Care Explor. 6 (2), e1052 (2024).","journal-title":"Crit. Care Explor."},{"issue":"Suppl 4","key":"30021_CR39","first-page":"S5","volume":"98","author":"A Duval","year":"2023","unstructured":"Duval, A. & Fremeaux-Bacchi, V. Complement biology for hematologists. Am. J. Hematol. 98 (Suppl 4), S5\u2013S19 (2023).","journal-title":"Am. J. Hematol."},{"issue":"22","key":"30021_CR40","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.15252\/embj.201591881","volume":"34","author":"G Bajic","year":"2015","unstructured":"Bajic, G. et al. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 34 (22), 2735\u20132757 (2015).","journal-title":"EMBO J."},{"issue":"1","key":"30021_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12500","volume":"274","author":"D Ricklin","year":"2016","unstructured":"Ricklin, D. et al. Complement component C3 - The Swiss army knife of innate immunity and host defense. Immunol. Rev. 274 (1), 33\u201358 (2016).","journal-title":"Immunol. Rev."},{"key":"30021_CR42","doi-asserted-by":"crossref","unstructured":"Frimat, M., Boudhabhay, I. & Roumenina, L. T. Hemolysis derived products toxicity and endothelium: model of the second hit. Toxins (Basel)  11 (11). (2019).","DOI":"10.3390\/toxins11110660"},{"issue":"3","key":"30021_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","volume":"168","author":"MU Muckenthaler","year":"2017","unstructured":"Muckenthaler, M. U. et al. A red carpet for iron metabolism. Cell 168 (3), 344\u2013361 (2017).","journal-title":"Cell"},{"issue":"0","key":"30021_CR44","first-page":"S47","volume":"55","author":"WA Flegel","year":"2015","unstructured":"Flegel, W. A. Pathogenesis and mechanisms of antibody-mediated hemolysis. Transfusion 55 (0), S47\u201358 (2015).","journal-title":"Transfusion"},{"key":"30021_CR45","doi-asserted-by":"crossref","unstructured":"Simunkova, M. et al. Antioxidant vs. Prooxidant properties of the Flavonoid, Kaempferol, in the presence of Cu(II) ions: A ROS-Scavenging Activity, Fenton reaction and DNA damage study. Int. J. Mol. Sci.  22 (4). (2021).","DOI":"10.3390\/ijms22041619"},{"issue":"4852","key":"30021_CR46","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.2834821","volume":"240","author":"JA Imlay","year":"1988","unstructured":"Imlay, J. A., Chin, S. M. & Linn, S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240 (4852), 640\u2013642 (1988).","journal-title":"Science"},{"key":"30021_CR47","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fphys.2018.01595","volume":"9","author":"T Gall","year":"2018","unstructured":"Gall, T. et al. Heme induces Endoplasmic reticulum stress (HIER stress) in human aortic smooth muscle cells. Front. Physiol. 9, 1595 (2018).","journal-title":"Front. Physiol."},{"issue":"1","key":"30021_CR48","doi-asserted-by":"publisher","first-page":"158492","DOI":"10.1016\/j.bbalip.2019.07.001","volume":"1865","author":"T Nishimura","year":"2020","unstructured":"Nishimura, T. & Stefan, C. J. Specialized ER membrane domains for lipid metabolism and transport. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1865 (1), 158492 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"issue":"7348","key":"30021_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature09968","volume":"473","author":"S Fu","year":"2011","unstructured":"Fu, S. et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver Endoplasmic reticulum stress in obesity. Nature 473 (7348), 528\u2013531 (2011).","journal-title":"Nature"},{"issue":"5","key":"30021_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cmet.2012.03.007","volume":"15","author":"S Fu","year":"2012","unstructured":"Fu, S., Watkins, S. M. & Hotamisligil, G. S. The role of Endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell. Metab. 15 (5), 623\u2013634 (2012).","journal-title":"Cell. Metab."},{"issue":"8","key":"30021_CR51","doi-asserted-by":"publisher","first-page":"e52280","DOI":"10.15252\/embr.202052280","volume":"23","author":"G Xing","year":"2022","unstructured":"Xing, G. et al. PPARalpha alleviates iron overload-induced ferroptosis in mouse liver. EMBO Rep. 23 (8), e52280 (2022).","journal-title":"EMBO Rep."},{"issue":"2","key":"30021_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41419-018-1135-3","volume":"10","author":"G Ye","year":"2019","unstructured":"Ye, G. et al. PPARalpha and PPARgamma activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the Inhibition of Fatp1 expression. Cell. Death Dis. 10 (2), 39 (2019).","journal-title":"Cell. Death Dis."},{"issue":"30","key":"30021_CR53","doi-asserted-by":"publisher","first-page":"27997","DOI":"10.1074\/jbc.M302140200","volume":"278","author":"M Fischer","year":"2003","unstructured":"Fischer, M. et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278 (30), 27997\u201328004 (2003).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"30021_CR54","doi-asserted-by":"publisher","first-page":"G262","DOI":"10.1152\/ajpgi.00129.2021","volume":"321","author":"A Mandala","year":"2021","unstructured":"Mandala, A. et al. PPARalpha agonist Fenofibrate attenuates iron-induced liver injury in mice by modulating the Sirt3 and beta-catenin signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 321 (4), G262\u2013G269 (2021).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"11","key":"30021_CR55","first-page":"695","volume":"12","author":"KV Kowdley","year":"2016","unstructured":"Kowdley, K. V. Iron overload in patients with chronic liver disease. Gastroenterol. Hepatol. (N Y). 12 (11), 695\u2013698 (2016).","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"issue":"5","key":"30021_CR56","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.tiv.2014.04.017","volume":"28","author":"S Sentellas","year":"2014","unstructured":"Sentellas, S. et al. GSSG\/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress. Toxicol. Vitro. 28 (5), 1006\u20131015 (2014).","journal-title":"Toxicol. Vitro"},{"issue":"1","key":"30021_CR57","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/s41598-018-23408-0","volume":"8","author":"E Agmon","year":"2018","unstructured":"Agmon, E. et al. Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci. Rep. 8 (1), 5155 (2018).","journal-title":"Sci. Rep."},{"issue":"10","key":"30021_CR58","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood-2011-08-375303","volume":"119","author":"GB Fortes","year":"2012","unstructured":"Fortes, G. B. et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 119 (10), 2368\u20132375 (2012).","journal-title":"Blood"},{"key":"30021_CR59","doi-asserted-by":"crossref","unstructured":"Cortese-Krott, M. M. The reactive species interactome in red blood cells: Oxidants, Antioxidants, and molecular targets. Antioxid. (Basel) 12 (9)  (2023).","DOI":"10.3390\/antiox12091736"},{"issue":"31","key":"30021_CR60","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1074\/jbc.R117.786632","volume":"292","author":"MD Knutson","year":"2017","unstructured":"Knutson, M. D. Iron transport proteins: gateways of cellular and systemic iron homeostasis. J. Biol. Chem. 292 (31), 12735\u201312743 (2017).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"30021_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0609.2010.01449.x","volume":"85","author":"JS Hankins","year":"2010","unstructured":"Hankins, J. S. et al. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload. Eur. J. Haematol. 85 (1), 51\u201357 (2010).","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"30021_CR62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2016.151621","volume":"102","author":"S Millot","year":"2017","unstructured":"Millot, S. et al. Hemolytic anemia repressed Hepcidin level without hepatocyte iron overload: lesson from Gunther disease model. Haematologica 102 (2), 260\u2013270 (2017).","journal-title":"Haematologica"},{"issue":"50","key":"30021_CR63","doi-asserted-by":"publisher","first-page":"E4922","DOI":"10.1073\/pnas.1314197110","volume":"110","author":"ER Anderson","year":"2013","unstructured":"Anderson, E. R. et al. Intestinal HIF2alpha promotes tissue-iron accumulation in disorders of iron overload with anemia. Proc. Natl. Acad. Sci. U S A. 110 (50), E4922\u2013E4930 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"Suppl 1","key":"30021_CR64","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1038\/modpathol.3800715","volume":"20","author":"KP Batts","year":"2007","unstructured":"Batts, K. P. Iron overload syndromes and the liver. Mod. Pathol. 20 (Suppl 1), S31\u2013S39 (2007).","journal-title":"Mod. Pathol."},{"issue":"2","key":"30021_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. Ferroptosis: past, present and future. Cell. Death Dis. 11 (2), 88 (2020).","journal-title":"Cell. Death Dis."},{"issue":"5","key":"30021_CR66","first-page":"447","volume":"83","author":"A Piperno","year":"1998","unstructured":"Piperno, A. Classification and diagnosis of iron overload. Haematologica 83 (5), 447\u2013455 (1998).","journal-title":"Haematologica"},{"issue":"2","key":"30021_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3164\/jcbn.10-76","volume":"48","author":"T Takami","year":"2011","unstructured":"Takami, T. & Sakaida, I. Iron regulation by hepatocytes and free radicals. J. Clin. Biochem. Nutr. 48 (2), 103\u2013106 (2011).","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"11","key":"30021_CR68","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-019-0181-0","volume":"15","author":"K Van Avondt","year":"2019","unstructured":"Van Avondt, K., Nur, E. & Zeerleder, S. Mechanisms of haemolysis-induced kidney injury. Nat. Rev. Nephrol. 15 (11), 671\u2013692 (2019).","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"30021_CR69","first-page":"435","volume":"108","author":"JL Martin-Ventura","year":"2012","unstructured":"Martin-Ventura, J. L. et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options. Thromb. Haemost. 108 (3), 435\u2013442 (2012).","journal-title":"Thromb. Haemost"},{"issue":"1","key":"30021_CR70","doi-asserted-by":"publisher","first-page":"e12549","DOI":"10.1111\/xen.12549","volume":"27","author":"S Nomura","year":"2020","unstructured":"Nomura, S. et al. Transgenic expression of human CD47 reduces phagocytosis of Porcine endothelial cells and podocytes by baboon and human macrophages. Xenotransplantation 27 (1), e12549 (2020).","journal-title":"Xenotransplantation"},{"issue":"4","key":"30021_CR71","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/cmi.2010.83","volume":"8","author":"N Navarro-Alvarez","year":"2011","unstructured":"Navarro-Alvarez, N. & Yang, Y. G. CD47: a new player in phagocytosis and xenograft rejection. Cell. Mol. Immunol. 8 (4), 285\u2013288 (2011).","journal-title":"Cell. Mol. Immunol."},{"issue":"17","key":"30021_CR72","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood.2020008563","volume":"137","author":"C Roussel","year":"2021","unstructured":"Roussel, C. et al. Rapid clearance of storage-induced microerythrocytes alters transfusion recovery. Blood 137 (17), 2285\u20132298 (2021).","journal-title":"Blood"},{"issue":"32","key":"30021_CR73","doi-asserted-by":"publisher","first-page":"26630","DOI":"10.1074\/jbc.M112.341255","volume":"287","author":"S Dey","year":"2012","unstructured":"Dey, S. et al. Impact of intravascular hemolysis in malaria on liver dysfunction: involvement of hepatic free Heme overload, NF-kappaB activation, and neutrophil infiltration. J. Biol. Chem. 287 (32), 26630\u201326646 (2012).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"30021_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.14218\/JCTH.2020.00022","volume":"8","author":"A Fierro-Fine","year":"2020","unstructured":"Fierro-Fine, A. et al. Clinical factors associated with hepatocellular iron deposition in End-stage liver disease. J. Clin. Transl Hepatol. 8 (3), 231\u2013239 (2020).","journal-title":"J. Clin. Transl Hepatol."},{"issue":"7","key":"30021_CR75","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1182\/blood.2024026109","volume":"145","author":"A D\u2019Alessandro","year":"2025","unstructured":"D\u2019Alessandro, A. et al. Ferroptosis regulates hemolysis in stored murine and human red blood cells. Blood 145 (7), 765\u2013783 (2025).","journal-title":"Blood"},{"issue":"5","key":"30021_CR76","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/sctm.16-0434","volume":"6","author":"CJ Hoornaert","year":"2017","unstructured":"Hoornaert, C. J. et al. Concise review: innate and adaptive immune recognition of allogeneic and xenogeneic cell transplants in the central nervous system. Stem Cells Transl Med. 6 (5), 1434\u20131441 (2017).","journal-title":"Stem Cells Transl Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30021-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:02:18Z","timestamp":1765972938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["30021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30021-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors J.H.S and N.Y.G are employed by the company Optipharm Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the Korea Institute of Toxicology. The TKO\/hGE experiment was approved under protocol number IAC-23-01-0627-0344. Approvals for the NC group (\n                      n\n                      \u2009=\u20093) were obtained under protocol numbers IAC-24-01-0031-0015, IAC-24-10-0131-0091, and IAC-23-01-0341-0333. All experiments were conducted in accordance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments). The authors confirm that all experiments were performed in compliance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"44014"}}